Literature DB >> 15472098

Inflammatory gene load is associated with enhanced inflammation and early carotid atherosclerosis in smokers.

Paula Jerrard-Dunne1, Matthias Sitzer, Paul Risley, Alexandra Buehler, Stefan von Kegler, Hugh S Markus.   

Abstract

BACKGROUND AND
PURPOSE: Smoking acts as a pro-inflammatory stimulus. Inflammation may provide a key mechanism by which smoking causes atherosclerosis. If so, then the degree to which an individual mounts an inflammatory response is likely to influence atherosclerosis severity. This study examined the impact of inflammatory gene polymorphisms and gene-smoking interactions on common carotid artery intima-media thickness (IMT), a measure of early atherosclerosis.
METHODS: In a community population (n=1000), mean IMT was determined using ultrasound. This population was genotyped for 6 polymorphisms in 4 inflammatory genes: IL-6-174, IL-6-572, and IL-6-597; IL-1-beta-31; IL-1 receptor antagonist VNTR and CD14-159. Serum IL-6 levels were measured in the first 500 subjects. Genotypes/haplotypes associated with higher IL-6 levels were designated "inflammatory haplotypes." A gene load score was calculated, in which 2 represented individuals homozygous for > or =2 inflammatory genotypes/haplotypes and 0 was homozygous for none.
RESULTS: Increasing gene load of inflammatory genotypes was associated with a linear increase in serum IL-6 levels (P=0.018) and increased carotid artery IMT (P=0.003). There was a significant interaction between gene load and smoking status on carotid IMT (P for interaction=0.002). Specifically, in smokers, carriers of inflammatory haplotypes had significantly increased age- and sex-adjusted IMT (IL-6-174C/IL-6-572G/IL-6-597A, P=0.005; IL-1-beta-31T/IL-1RN*2,P=0.04; CD14-159CC, P=0.028).
CONCLUSIONS: These findings support the hypothesis that inflammation and cytokine responses provide a key mechanism by which smoking causes atherogenesis. Secondly, they highlight the importance of gene-environment, and gene-gene-environment interactions in the pathogenesis of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15472098     DOI: 10.1161/01.STR.0000144681.46696.b3

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  16 in total

1.  Association of IL-6 polymorphisms with hepatocellular carcinoma risk: evidences from a meta-analysis.

Authors:  Ying Liu; Su-jun Gao; Bo-xiang Du; Jie-jun Wang
Journal:  Tumour Biol       Date:  2013-12-08

Review 2.  Genetic determinants of carotid ultrasound traits.

Authors:  Rebecca L Pollex; Robert Hegele
Journal:  Curr Atheroscler Rep       Date:  2006-05       Impact factor: 5.113

Review 3.  Genetic Risk Factors of Intracranial Atherosclerosis.

Authors:  Minghua Liu; Jose Gutierrez
Journal:  Curr Atheroscler Rep       Date:  2020-05-21       Impact factor: 5.113

Review 4.  Influence of interleukin polymorphisms on development of gastric cancer and peptic ulcer.

Authors:  Mitsushige Sugimoto; Yoshio Yamaoka; Takahisa Furuta
Journal:  World J Gastroenterol       Date:  2010-03-14       Impact factor: 5.742

5.  Serum cholinesterase activities distinguish between stroke patients and controls and predict 12-month mortality.

Authors:  Einor Ben Assayag; Shani Shenhar-Tsarfaty; Keren Ofek; Lilach Soreq; Irena Bova; Ludmila Shopin; Ronan M G Berg; Shlomo Berliner; Itzhak Shapira; Natan M Bornstein; Hermona Soreq
Journal:  Mol Med       Date:  2010-04-14       Impact factor: 6.354

6.  A combination of alleles 2 of interleukin (IL)-1A(-889) and IL-1B(+3954) is associated with lower gingival bleeding tendency in plaque-induced gingivitis in young adults of Arabic heritage.

Authors:  H P Müller; K M Barrieshi-Nusair
Journal:  Clin Oral Investig       Date:  2007-05-11       Impact factor: 3.573

7.  The relationship between race, cigarette smoking and carotid intimal medial thickness in systemic lupus erythematosus.

Authors:  L V Scalzi; S Bhatt; R C Gilkeson; M L Shaffer
Journal:  Lupus       Date:  2009-10-27       Impact factor: 2.911

8.  Influence of C-159T SNP of the CD14 gene promoter on lung function in smokers.

Authors:  Haibo Zhou; Neil E Alexis; Martha Almond; James Donohue; Craig LaForce; Philip A Bromberg; David B Peden
Journal:  Respir Med       Date:  2009-04-10       Impact factor: 3.415

9.  Role of TLR4 (C1196T) and CD14 (C-260T) Polymorphisms in Development of Ischemic Stroke, Its Subtypes and Hemorrhagic Stroke.

Authors:  Satrupa Das; Subhash Kaul; Akka Jyothy; Anjana Munshi
Journal:  J Mol Neurosci       Date:  2017-09-30       Impact factor: 3.444

10.  Ischemic stroke risk, smoking, and the genetics of inflammation in a biracial population: the stroke prevention in young women study.

Authors:  John W Cole; David W Brown; Wayne H Giles; Oscar C Stine; Jeffrey R O'Connell; Braxton D Mitchell; John D Sorkin; Marcella A Wozniak; Barney J Stern; Mary J Sparks; Mark T Dobbins; Latasha T Shoffner; Nancy K Zappala; Laurie J Reinhart; Steven J Kittner
Journal:  Thromb J       Date:  2008-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.